 鲜花( 85)  鸡蛋( 2)
|

楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval) F. U- w9 E t4 |7 {: S% V' ]
4 N2 [( j2 N3 v8 D
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
9 F! U0 F: b7 @; U0 D8 z8 T: J. `
4 K& L E4 R$ C8 p4 ]BY THE EDMONTON JOURNAL FEBRUARY 16, 2007! E, ?1 W/ k+ G1 }: [
q |2 i9 ?) a# l& j 6 {) Q3 x2 l, M
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
4 M0 H8 ~: P K, p& I5 j( c R. f* z ]4 B1 w* Y; F" T. Z- q( e& G
The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."
0 R& p% i1 E6 ^
. ^/ F4 w, V( k9 `+ nThe APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.
" ?; k' y! ^3 h7 O! p; V6 M* A4 {8 p
It should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.
0 d& e% N# c" D
# v2 C. N4 H" m0 y. P. W, y* {It certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.
; U) L8 W+ w- ?6 ^7 f+ }' w1 j8 U& c0 X% |
"As a scientist, it's one of the highlights of my CAREER," Shan said.# S/ j8 ~: m- Z) t/ K4 \5 f
5 A% J! B# K% Y"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."; x* u$ n4 I0 o; E; t( n
: d) p, p# X, W
It's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.) w; t2 S5 b1 z# h% z* r6 g
5 U) s9 G0 A$ v, j9 W) NGinseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.5 s' M6 A1 p" F+ E; n$ ]
: T' X/ ^& X3 }7 h( W" w# F! Q
The approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.5 X- } o. R8 p
$ ~4 D/ a/ X) y. j3 h: d
3 p, |: D3 [# U, ~" chttp://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|